MORISHITA JINTAN CO.,LTD. Logo

MORISHITA JINTAN CO.,LTD.

Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.

4524 | T

Overview

Corporate Details

ISIN(s):
JP3924400009
LEI:
Country:
Japan
Address:
大阪市中央区玉造一丁目2番40号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1893, Morishita Jintan Co., Ltd. is a multifaceted healthcare company engaged in the manufacture and sale of health-related products. The company's portfolio includes pharmaceuticals, quasi-drugs, medical devices, cosmetics, and health foods such as dietary supplements and probiotics. It is well-known for its 'Jintan' brand of oral care products. In addition to its direct-to-consumer offerings, Morishita Jintan provides Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services for the pharmaceutical and food industries, utilizing its expertise in advanced encapsulation technology to deliver high-quality, innovative healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-12 07:34
Registration Form
確認書
Japanese 8.2 KB
2025-11-12 07:32
Interim Report
半期報告書-第89期(2025/04/01-2025/09/30)
Japanese 172.4 KB
2025-06-26 06:56
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-06-20 08:44
Registration Form
確認書
Japanese 8.1 KB
2025-06-20 08:41
Governance Information
内部統制報告書-第88期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-20 08:35
Annual Report
有価証券報告書-第88期(2024/04/01-2025/03/31)
Japanese 1.1 MB
2024-11-12 07:15
Interim Report
半期報告書-第88期(2024/04/01-2025/03/31)
Japanese 179.7 KB
2024-11-12 07:13
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-06-27 04:45
Post-Annual General Meeting Information
臨時報告書
Japanese 24.9 KB
2024-06-26 06:23
Registration Form
確認書
Japanese 8.1 KB
2024-06-26 06:22
Governance Information
内部統制報告書-第87期(2023/04/01-2024/03/31)
Japanese 22.2 KB
2024-06-26 06:21
Annual Report
有価証券報告書-第87期(2023/04/01-2024/03/31)
Japanese 1.0 MB
2024-02-08 05:32
Regulatory News Service
確認書
Japanese 8.1 KB
2024-02-08 05:31
Quarterly Report
四半期報告書-第87期第3四半期(2023/10/01-2023/12/31)
Japanese 162.1 KB
2023-11-09 05:31
Report Publication Announcement
確認書
Japanese 8.1 KB

Automate Your Workflow. Get a real-time feed of all MORISHITA JINTAN CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MORISHITA JINTAN CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MORISHITA JINTAN CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany
BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland
BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
BIOVIE INC. Logo
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology drugs targeting mutation families in lung and brain cancers.
United States of America
BDTX
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea
065170

Talk to a Data Expert

Have a question? We'll get back to you promptly.